Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Cerebral Small Vessel Disease | Research

Chronic gastritis may predict risk of cerebral small vessel disease

Authors: Cunsheng Wei, Chang Tan, Xuemei Zhang, Xin Shen, Zongliang Xu, Junrong Li, Gelin Xu

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background and purpose

Chronic gastritis, especially that caused by helicobacter pylori (HP) infection, has been associated with increased risk of ischemic stroke. But the relationship between chronic gastritis and cerebral small vessel disease (CSVD) remains largely undetermined. This study aimed to determine the potential predictors for CSVD, with chronic gastritis and its proxies as alternatives.

Method

Patients aged 18 years or older with indications for electronic gastroscopy were enrolled. Presence of CSVD was evaluated with brain magnetic resonance imaging (MRI) results. Degree of CSVD was scored according to established criteria. Logistic regression analysis was used for identifying possible risk factors for CSVD.

Results

Of the 1191 enrolled patients, 757 (63.6%) were identified as with, and 434 (36.4%) as without CSVD. Multivariate analysis indicated that patients with chronic atrophic gastritis had an increased risk for CSVD than those without (adjusted odds ratio = 1.58; 95% CI, 1.08–2.32; P < 0.05).

Conclusions

Chronic atrophic gastritis is associated with the presence of CSVD. We should routinely screen the presence of CSVD for patients with chronic atrophic gastritis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wiegertjes K, Ter Telgte A, Oliveira PB, et al. The role of small diffusion-weighted imaging lesions in cerebral small vessel disease. Neurology. 2019;93:e1627–34.CrossRefPubMed Wiegertjes K, Ter Telgte A, Oliveira PB, et al. The role of small diffusion-weighted imaging lesions in cerebral small vessel disease. Neurology. 2019;93:e1627–34.CrossRefPubMed
2.
go back to reference Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. The Lancet Neurology. 2013;12:483–97.CrossRefPubMed Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. The Lancet Neurology. 2013;12:483–97.CrossRefPubMed
3.
go back to reference Georgakis MK, Duering M, Wardlaw JM, Dichgans M. WMH and long-term outcomes in ischemic stroke: a systematic review and meta-analysis. Neurology. 2019;92:e1298–308.CrossRefPubMed Georgakis MK, Duering M, Wardlaw JM, Dichgans M. WMH and long-term outcomes in ischemic stroke: a systematic review and meta-analysis. Neurology. 2019;92:e1298–308.CrossRefPubMed
4.
go back to reference Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42:2672–713.CrossRefPubMedPubMedCentral Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42:2672–713.CrossRefPubMedPubMedCentral
5.
go back to reference Low A, Mak E, Rowe JB, Markus HS, O’Brien JT. Inflammation and cerebral small vessel disease: a systematic review. Ageing Res Rev. 2019;53: 100916.CrossRefPubMed Low A, Mak E, Rowe JB, Markus HS, O’Brien JT. Inflammation and cerebral small vessel disease: a systematic review. Ageing Res Rev. 2019;53: 100916.CrossRefPubMed
6.
go back to reference Rouhl RPW, Damoiseaux JGMC, Lodder J, et al. Vascular inflammation in cerebral small vessel disease. Neurobiol Aging. 2012;33:1800–6.CrossRefPubMed Rouhl RPW, Damoiseaux JGMC, Lodder J, et al. Vascular inflammation in cerebral small vessel disease. Neurobiol Aging. 2012;33:1800–6.CrossRefPubMed
7.
go back to reference Aribisala BS, Wiseman S, Morris Z, et al. Circulating inflammatory markers are associated with magnetic resonance imaging-visible perivascular spaces but not directly with white matter hyperintensities. Stroke. 2014;45:605–7.CrossRefPubMedPubMedCentral Aribisala BS, Wiseman S, Morris Z, et al. Circulating inflammatory markers are associated with magnetic resonance imaging-visible perivascular spaces but not directly with white matter hyperintensities. Stroke. 2014;45:605–7.CrossRefPubMedPubMedCentral
8.
go back to reference Fan F, Yang C, Zhu X, et al. Association between infectious burden and cerebral microbleeds: a pilot cross-sectional study. Ann Clin Transl Neurol. 2021;8:395–405.CrossRefPubMedPubMedCentral Fan F, Yang C, Zhu X, et al. Association between infectious burden and cerebral microbleeds: a pilot cross-sectional study. Ann Clin Transl Neurol. 2021;8:395–405.CrossRefPubMedPubMedCentral
9.
go back to reference Staszewski J, Piusińska-Macoch R, Brodacki B, Skrobowska E, Stępień A. IL-6, PF-4, sCD40 L, and homocysteine are associated with the radiological progression of cerebral small-vessel disease: a 2-year follow-up study. Clin Interv Aging. 2018;13:1135–41.CrossRefPubMedPubMedCentral Staszewski J, Piusińska-Macoch R, Brodacki B, Skrobowska E, Stępień A. IL-6, PF-4, sCD40 L, and homocysteine are associated with the radiological progression of cerebral small-vessel disease: a 2-year follow-up study. Clin Interv Aging. 2018;13:1135–41.CrossRefPubMedPubMedCentral
10.
go back to reference Walker KA, Power MC, Hoogeveen RC, et al. Midlife systemic inflammation, late-life white matter integrity, and cerebral small vessel disease: the atherosclerosis risk in communities study. Stroke. 2017;48:3196–202.CrossRefPubMedPubMedCentral Walker KA, Power MC, Hoogeveen RC, et al. Midlife systemic inflammation, late-life white matter integrity, and cerebral small vessel disease: the atherosclerosis risk in communities study. Stroke. 2017;48:3196–202.CrossRefPubMedPubMedCentral
11.
go back to reference Doheim MF, Altaweel AA, Elgendy MG, et al. Association between Helicobacter Pylori infection and stroke: a meta-analysis of 273,135 patients. J Neurol. 2021;268:3238–48. Doheim MF, Altaweel AA, Elgendy MG, et al. Association between Helicobacter Pylori infection and stroke: a meta-analysis of 273,135 patients. J Neurol. 2021;268:3238–48.
12.
go back to reference Jiang J, Chen Y, Shi J, Song C, Zhang J, Wang K. Population attributable burden of Helicobacter pylori-related gastric cancer, coronary heart disease, and ischemic stroke in China. Eur J Clin Microbiol Infect Dis. 2017;36:199–212.CrossRefPubMed Jiang J, Chen Y, Shi J, Song C, Zhang J, Wang K. Population attributable burden of Helicobacter pylori-related gastric cancer, coronary heart disease, and ischemic stroke in China. Eur J Clin Microbiol Infect Dis. 2017;36:199–212.CrossRefPubMed
13.
go back to reference Shindler-Itskovitch T, Chodick G, Shalev V, Muhsen K. Helicobacter pylori infection and prevalence of stroke. Helicobacter. 2019;24: e12553.CrossRefPubMed Shindler-Itskovitch T, Chodick G, Shalev V, Muhsen K. Helicobacter pylori infection and prevalence of stroke. Helicobacter. 2019;24: e12553.CrossRefPubMed
14.
go back to reference Ren JR, Ren SH, Ning B, et al. Hyperhomocysteinemia as a risk factor for saccular intracranial aneurysm: a cohort study in a Chinese Han population. J Stroke Cerebrovasc Dis. 2017;26:2720–6.CrossRefPubMed Ren JR, Ren SH, Ning B, et al. Hyperhomocysteinemia as a risk factor for saccular intracranial aneurysm: a cohort study in a Chinese Han population. J Stroke Cerebrovasc Dis. 2017;26:2720–6.CrossRefPubMed
15.
go back to reference Tang D, Wang L, Ling T, et al. Development and validation of a real-time artificial intelligence-assisted system for detecting early gastric cancer: a multicentre retrospective diagnostic study. EBioMedicine. 2020;62:103146–103146.CrossRefPubMedPubMedCentral Tang D, Wang L, Ling T, et al. Development and validation of a real-time artificial intelligence-assisted system for detecting early gastric cancer: a multicentre retrospective diagnostic study. EBioMedicine. 2020;62:103146–103146.CrossRefPubMedPubMedCentral
16.
go back to reference Lau KK, Li L, Schulz U, et al. Total small vessel disease score and risk of recurrent stroke: validation in 2 large cohorts. Neurology. 2017;88:2260–7.CrossRefPubMedPubMedCentral Lau KK, Li L, Schulz U, et al. Total small vessel disease score and risk of recurrent stroke: validation in 2 large cohorts. Neurology. 2017;88:2260–7.CrossRefPubMedPubMedCentral
17.
go back to reference Du H, Wilson D, Ambler G, et al. Small vessel disease and ischemic stroke risk during anticoagulation for atrial fibrillation after cerebral ischemia. Stroke. 2021;52:91–9.CrossRefPubMed Du H, Wilson D, Ambler G, et al. Small vessel disease and ischemic stroke risk during anticoagulation for atrial fibrillation after cerebral ischemia. Stroke. 2021;52:91–9.CrossRefPubMed
18.
go back to reference Xiao L, Lan W, Sun W, et al. Chronic kidney disease in patients with lacunar stroke: association with enlarged perivascular spaces and total magnetic resonance imaging burden of cerebral small vessel disease. Stroke. 2015;46:2081–6.CrossRefPubMed Xiao L, Lan W, Sun W, et al. Chronic kidney disease in patients with lacunar stroke: association with enlarged perivascular spaces and total magnetic resonance imaging burden of cerebral small vessel disease. Stroke. 2015;46:2081–6.CrossRefPubMed
19.
go back to reference Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. the updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.CrossRefPubMed Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. the updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.CrossRefPubMed
20.
go back to reference Warsch JR, Wright CB. Stroke: hyperlipidemia and cerebral small-vessel disease. Nat Rev Neurol. 2010;6:307–8.CrossRefPubMed Warsch JR, Wright CB. Stroke: hyperlipidemia and cerebral small-vessel disease. Nat Rev Neurol. 2010;6:307–8.CrossRefPubMed
22.
go back to reference Wardlaw JM, Allerhand M, Doubal FN, et al. Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities. Neurology. 2014;82:1331–8.CrossRefPubMedPubMedCentral Wardlaw JM, Allerhand M, Doubal FN, et al. Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities. Neurology. 2014;82:1331–8.CrossRefPubMedPubMedCentral
23.
go back to reference Zhou LW, Panenka WJ, Al-Momen G, et al. Cerebral small vessel disease, risk factors, and cognition in tenants of precarious housing. Stroke. 2020;51:3271–8.CrossRefPubMed Zhou LW, Panenka WJ, Al-Momen G, et al. Cerebral small vessel disease, risk factors, and cognition in tenants of precarious housing. Stroke. 2020;51:3271–8.CrossRefPubMed
24.
go back to reference Massironi S, Zilli A, Elvevi A, Invernizzi P. The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective. Autoimmun Rev. 2019;18:215–22.CrossRefPubMed Massironi S, Zilli A, Elvevi A, Invernizzi P. The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective. Autoimmun Rev. 2019;18:215–22.CrossRefPubMed
25.
go back to reference Neumann WL, Coss E, Rugge M, Genta RM. Autoimmune atrophic gastritis–pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013;10:529–41.CrossRefPubMed Neumann WL, Coss E, Rugge M, Genta RM. Autoimmune atrophic gastritis–pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013;10:529–41.CrossRefPubMed
26.
go back to reference Mangoni AA, Jackson SH. Homocysteine and cardiovascular disease: current evidence and future prospects. Am J Med. 2002;112:556–65.CrossRefPubMed Mangoni AA, Jackson SH. Homocysteine and cardiovascular disease: current evidence and future prospects. Am J Med. 2002;112:556–65.CrossRefPubMed
27.
go back to reference Li Y, Huang T, Zheng Y, Muka T, Troup J, Hu FB. Folic acid supplementation and the risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2016;5(8):e003768.CrossRefPubMedPubMedCentral Li Y, Huang T, Zheng Y, Muka T, Troup J, Hu FB. Folic acid supplementation and the risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2016;5(8):e003768.CrossRefPubMedPubMedCentral
28.
go back to reference Huo Y, Li J, Qin X, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA. 2015;313:1325–35.CrossRefPubMed Huo Y, Li J, Qin X, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA. 2015;313:1325–35.CrossRefPubMed
29.
go back to reference Rodriguez-Castro KI, Franceschi M, Noto A, et al. Clinical manifestations of chronic atrophic gastritis. Acta Biomed. 2018;89:88–92.PubMed Rodriguez-Castro KI, Franceschi M, Noto A, et al. Clinical manifestations of chronic atrophic gastritis. Acta Biomed. 2018;89:88–92.PubMed
30.
go back to reference Cao L, Guo Y, Zhu Z. Effects of hyperhomocysteinemia on ischemic cerebral small vessel disease and analysis of inflammatory mechanisms. Int J Neurosci. 2021;131:362–9.CrossRefPubMed Cao L, Guo Y, Zhu Z. Effects of hyperhomocysteinemia on ischemic cerebral small vessel disease and analysis of inflammatory mechanisms. Int J Neurosci. 2021;131:362–9.CrossRefPubMed
Metadata
Title
Chronic gastritis may predict risk of cerebral small vessel disease
Authors
Cunsheng Wei
Chang Tan
Xuemei Zhang
Xin Shen
Zongliang Xu
Junrong Li
Gelin Xu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-03009-6

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.